US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ARK Genomic Revolution ETF

49.45

+1.813.80%

Post-market: 49.650.2000+0.40%19:58 EDT

Volume:11.30M

Turnover:555.26M

Market Cap:2.00B

PE:- -

High:49.56

Open:47.93

Low:47.55

Close:47.64

52wk High:49.56

52wk Low:24.20

Shares:40.35M

Float Shares:40.35M

Volume Ratio:3.27

T/O Rate:28.00%

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Carbonium Core Reports Rare Earth and Critical Mineral Content in Initial Sample Assay

Twist Bioscience Corporation Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS

Press Release: REMAX and Real Remind Stockholders of Deadline to Elect Form of Merger Consideration

Tempus AI Inc : Btig Cuts Target Price to $70 from $80

THOMSON REUTERS

Twist Bioscience Corp : Leerink Partners Raises Target Price $120.00 from $110.00

THOMSON REUTERS

Crispr Therapeutics AG Reports Results for the Quarter Ended June 30 - Earnings Summary

QUICK SPARK: SpaceX Tops Cathie Wood's Shopping List With $26 Million Bet Ahead Of First Earnings

Benzinga_recent_news

Crispr Therapeutics Q2 FY26 Net Loss Narrows to $91.2 Million; Casgevy Revenue Rises 151% Year over Year to $76 Million

Analysts Are Bullish on Top Healthcare Stocks: Ocular Therapeutix (OCUL), Twist Bioscience (TWST)

Analysts Offer Insights on Healthcare Companies: Tempus AI, Inc. Class A (TEM) and Rocket Pharmaceuticals (RCKT)

Tempus AI price target lowered to $56 from $64 at H.C. Wainwright

Twist Bioscience Corp Reports Results for the Quarter Ended June 30 - Earnings Summary

Tempus AI is Maintained at Hold by Stifel

Twist Bioscience Q3 EPS $(0.56) Misses $(0.50) Estimate, Sales $118.376M Beat $114.490M Estimate

Benzinga Earnings

Twist Bioscience FY26 Q3 Adjusted Ebitda Loss Narrows to $(11.3) Million; Revenue Rises 23% YoY to $118.4 Million

Twist Bioscience Q3 EPS USD -0.56

THOMSON REUTERS

Twist Bioscience Outlook Q4 to Achieve Adjusted Ebitda Breakeven

THOMSON REUTERS

Twist Bioscience Outlook FY Gross Margin to be Above 52%

THOMSON REUTERS

Twist Bioscience Posts Fiscal Q3 2026 Earnings Report and Investor Presentation Online

Twist Bioscience Corp: for the Fourth Quarter, Twist Expects Total Revenue of Approximately $123 Million to $124 Million

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/ARKG/news?page=9"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ARKG","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ARKG\",,,,,undefined,":{"symbol":"ARKG","market":"US","secType":"STK","nameCN":"ARK Genomic Revolution ETF","latestPrice":49.45,"timestamp":1787342400000,"preClose":47.64,"halted":0,"volume":11296438,"hourTrading":{"tag":"盘后","latestPrice":49.65,"preClose":49.45,"latestTime":"19:58 EDT","volume":56956,"amount":2819630.4284,"timestamp":1787356682401,"change":0.2,"changeRate":0.004044,"amplitude":0.013124},"delay":0,"changeRate":0.03799328295549963,"floatShares":40350000,"shares":40350000,"eps":0,"marketStatus":"Market Closed","change":1.81,"latestTime":"08-21 16:00:00 EDT","open":47.93,"high":49.56,"low":47.545,"amount":555257262.42759,"amplitude":0.042296,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787558400000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"CBOE","adjPreClose":47.64,"sharesOutstanding":39900000,"nav":47.644442,"aum":1979577971.9,"bidAskSpread":0.000209,"preHourTrading":{"tag":"盘前","latestPrice":47.9,"preClose":47.64,"latestTime":"09:26 EDT","volume":20719,"amount":999516.4672600001,"timestamp":1787318780899,"change":0.26,"changeRate":0.005458,"amplitude":0.024291},"postHourTrading":{"tag":"盘后","latestPrice":49.65,"preClose":49.45,"latestTime":"19:58 EDT","volume":56956,"amount":2819630.4284,"timestamp":1787356682401,"change":0.2,"changeRate":0.004044,"amplitude":0.013124},"volumeRatio":3.2679704792909074,"impliedVol":0.4949,"impliedVolPercentile":0.4104},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ARKG\",,,,,undefined,":{"symbol":"ARKG","floatShares":40350000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":3.2679704792909074,"shares":40350000,"dividePrice":0,"high":49.56,"amplitude":0.042296,"preClose":47.64,"low":47.545,"week52Low":24.2,"pbRate":"--","week52High":49.56,"institutionHeld":0,"latestPrice":49.45,"eps":0,"divideRate":0,"volume":11296438,"delay":0,"ttmEps":0,"open":47.93,"prevYearClose":28.97,"prevWeekClose":43.45,"prevMonthClose":38.56,"prevQuarterClose":42.06,"fiveDayClose":43.45,"twentyDayClose":37.81,"sixtyDayClose":32.06},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ARKG\",params:#limit:5,,,undefined,":[{"market":"US","date":"2021-12-29","symbol":"ARKG","amount":0.38239,"defaultRemindTime":1640788200000,"name":"ARK Genomic Revolution Multi-Sector ETF","recordDate":"2021-12-31","payableDate":"2021-12-30","currency":"USD","type":"dividend","dateTimestamp":1640754000000},{"market":"US","date":"2020-12-29","symbol":"ARKG","amount":0.36456,"name":"ARK Genomic Revolution Multi-Sector ETF","recordDate":"2020-12-31","payableDate":"2020-12-30","currency":"USD","type":"dividend","dateTimestamp":1609218000000},{"market":"US","date":"2019-12-27","symbol":"ARKG","amount":1.05395,"name":"ARK Genomic Revolution Multi-Sector ETF","recordDate":"2019-12-31","payableDate":"2019-12-30","currency":"USD","type":"dividend","dateTimestamp":1577422800000},{"market":"US","date":"2018-12-27","symbol":"ARKG","amount":0.26999,"name":"ARK Genomic Revolution Multi-Sector ETF","recordDate":"2018-12-31","payableDate":"2018-12-28","currency":"USD","type":"dividend","dateTimestamp":1545886800000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ARKG\",market:\"US\",,,undefined,":[{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2018-12-31","value":0.26999,"currency":"USD"},{"executeDate":"2019-12-27","recordDate":"2019-12-30","paymentDate":"2019-12-31","value":1.05395,"currency":"USD"},{"executeDate":"2020-12-29","recordDate":"2020-12-30","paymentDate":"2020-12-31","value":0.36456,"currency":"USD"},{"executeDate":"2021-12-29","recordDate":"2021-12-30","paymentDate":"2021-12-31","value":0.38239,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ARKG\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ARKG\",pageSize:20,pageCount:9,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2656556458","title":"Carbonium Core Reports Rare Earth and Critical Mineral Content in Initial Sample Assay","url":"https://stock-news.laohu8.com/highlight/detail?id=2656556458","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656556458?lang=en_us&edition=fundamental","pubTime":"2026-08-04 20:30","pubTimestamp":1785846600,"startTime":"0","endTime":"0","summary":"Multi-element analysis returns elevated concentrations of both light and heavy rare earth elements, along with a broad suite of industrial metalsFREDERICK, Md., Aug.  04, 2026  (GLOBE NEWSWIRE) -- TOM","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/04/3338317/34752/en/Carbonium-Core-Reports-Rare-Earth-and-Critical-Mineral-Content-in-Initial-Sample-Assay.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WEPN","IBAT","BK4019","NSI","BK4585","WDIG","HALX","FMTL","Y","BK4588","REMX","ZSB","POW","AKAF","TOMZ","BK4544","PWER","BK4120","TURF","CRIT","EVMT","CCSO","CTEC","EART","FXZ","ARKG","FTWO","GSFP","MVPS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656553727","title":"Twist Bioscience Corporation Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2656553727","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656553727?lang=en_us&edition=fundamental","pubTime":"2026-08-04 20:00","pubTimestamp":1785844801,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nTUA4NC4DN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["WDNA","BK4588","TWST","ARKG","GNOM","IDNA","BK4139","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656555879","title":"Press Release: REMAX and Real Remind Stockholders of Deadline to Elect Form of Merger Consideration","url":"https://stock-news.laohu8.com/highlight/detail?id=2656555879","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656555879?lang=en_us&edition=fundamental","pubTime":"2026-08-04 20:00","pubTimestamp":1785844800,"startTime":"0","endTime":"0","summary":"Election Deadline for Record Holders is 5:00 p.m. New York City time on August 18, 2026DENVER, Aug. 4, 2026 /PRNewswire/ -- RE/MAX Holdings, Inc. (\"REMAX\") (NYSE: RMAX) and The Real Brokerage Inc. (\"R","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4079","REAX","ARKG","RMAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656320584","title":"Tempus AI Inc : Btig Cuts Target Price to $70 from $80","url":"https://stock-news.laohu8.com/highlight/detail?id=2656320584","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656320584?lang=en_us&edition=fundamental","pubTime":"2026-08-04 12:47","pubTimestamp":1785818835,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nFWN4410CE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4613","TEM","ARKG","LU1861559042.SGD","TEMT","BK4121","BK4611","LU1861558580.USD","HEAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656581693","title":"Twist Bioscience Corp : Leerink Partners Raises Target Price $120.00 from $110.00","url":"https://stock-news.laohu8.com/highlight/detail?id=2656581693","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656581693?lang=en_us&edition=fundamental","pubTime":"2026-08-04 11:58","pubTimestamp":1785815935,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nFWN4401IT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4588","IDNA","BK4139","WDNA","TWST","GNOM","ARKG","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656830710","title":"Crispr Therapeutics AG Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2656830710","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656830710?lang=en_us&edition=fundamental","pubTime":"2026-08-04 05:38","pubTimestamp":1785793117,"startTime":"0","endTime":"0","summary":"CRISPR Therapeutics AG reports results for the quarter ended June 30 - Earnings SummaryCRISPR Therapeutics AGCRSP.OQreported a quarterly adjusted loss of 94 cents per share for the quarter ended June ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nL8N4402J5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LU1861558580.USD","BK4611","LU1861559042.SGD","BK4585","ARKG","BK4556","CRSP","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656307473","title":"QUICK SPARK: SpaceX Tops Cathie Wood's Shopping List With $26 Million Bet Ahead Of First Earnings","url":"https://stock-news.laohu8.com/highlight/detail?id=2656307473","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656307473?lang=en_us&edition=fundamental","pubTime":"2026-08-04 04:30","pubTimestamp":1785789000,"startTime":"0","endTime":"0","summary":"Cathie Wood bought SpaceX again ahead of its first earnings, while boosting bets on Tesla, Nvidia, CoreWeave and other AI and defense stocks.","market":"us","thumbnail":"https://cdn.benzinga.com/cdn-cgi/image/width=3840,format=auto,quality=85/files/images/story/2026/08/03/ARK-Invest-Photo-Cathie-Wood-3.png","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/cdn-cgi/image/width=3840,format=auto,quality=85/files/images/story/2026/08/03/ARK-Invest-Photo-Cathie-Wood-3.png"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/etfs/sector-etfs/26/08/60890654/quick-spark-spacex-tops-cathie-woods-shopping-list-with-26-million-bet-ahead-of-first-earnings","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/etfs/sector-etfs/26/08/60890654/quick-spark-spacex-tops-cathie-woods-shopping-list-with-26-million-bet-ahead-of-first-earnings","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["DXYZ","ARKW","ARKG","SNK","SARK","ARKQ","ARKX","ARKK","XOVR","ARKF","SPAL","SPCU","SPCX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656230453","title":"Crispr Therapeutics Q2 FY26 Net Loss Narrows to $91.2 Million; Casgevy Revenue Rises 151% Year over Year to $76 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2656230453","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656230453?lang=en_us&edition=fundamental","pubTime":"2026-08-04 04:22","pubTimestamp":1785788541,"startTime":"0","endTime":"0","summary":"CRISPR Therapeutics Q2 FY26 net loss narrows to $91.2 million; CASGEVY revenue rises 151% year over year to $76 millionCRISPR Therapeutics posted a Q2 net loss of $91.2 million, narrowing from $208.5 ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nNDLcnb8h:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","LU1861558580.USD","SG9999014005.SGD","IE00BKPKM429.USD","BK4588","LU0314104364.USD","LU1861559042.SGD","LU2095319765.USD","BK4139","ARKG","BK4585","IE00BN0W2V16.EUR","BK4611","BK4556","LU2210150020.SGD","BCDF","NDAQ","SG9999014013.SGD","IE00B3QW5Z07.USD","BK4112","IE00BN0W2W23.USD","SG9999014039.USD","SG9999014021.USD","IE00BGHQF748.EUR","IE00BN0W2T93.GBP","IE00B64PRP62.GBP","CRSP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656306737","title":"Analysts Are Bullish on Top Healthcare Stocks: Ocular Therapeutix (OCUL), Twist Bioscience (TWST)","url":"https://stock-news.laohu8.com/highlight/detail?id=2656306737","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656306737?lang=en_us&edition=fundamental","pubTime":"2026-08-04 03:00","pubTimestamp":1785783614,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Ocular Therapeutix (OCUL) and Twist Bioscience (TWST...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-ocular-therapeutix-ocul-twist-bioscience-twst-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-ocular-therapeutix-ocul-twist-bioscience-twst-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["WDNA","TWST","BK4139","BK4588","BK4585","BK4007","ARKG","OCUL","IDNA","GNOM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656305691","title":"Analysts Offer Insights on Healthcare Companies: Tempus AI, Inc. Class A (TEM) and Rocket Pharmaceuticals (RCKT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2656305691","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656305691?lang=en_us&edition=fundamental","pubTime":"2026-08-04 01:40","pubTimestamp":1785778806,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Tempus AI, Inc. Class A (TEM) and Rocket Pharmaceuti...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-tempus-ai-inc-class-a-tem-and-rocket-pharmaceuticals-rckt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-tempus-ai-inc-class-a-tem-and-rocket-pharmaceuticals-rckt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RCKT","HEAL","BK4611","ARKG","LU1861559042.SGD","LU1861558580.USD","BK4121","BK4613","BK4139","TEMT","TEM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656630306","title":"Tempus AI price target lowered to $56 from $64 at H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2656630306","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656630306?lang=en_us&edition=fundamental","pubTime":"2026-08-04 01:15","pubTimestamp":1785777323,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Yi Chen lowered the firm’s price target on Tempus AI (TEM) to $56 from $64 and keeps a Buy rating on the shares. The compan...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/tempus-ai-price-target-lowered-to-56-from-64-at-h-c-wainwright-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/tempus-ai-price-target-lowered-to-56-from-64-at-h-c-wainwright-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1861558580.USD","LU1861559042.SGD","BK4613","HEAL","BK4611","ARKG","BK4121","TEMT","TEM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656372169","title":"Twist Bioscience Corp Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2656372169","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656372169?lang=en_us&edition=fundamental","pubTime":"2026-08-03 22:06","pubTimestamp":1785765993,"startTime":"0","endTime":"0","summary":"Twist Bioscience Corp reports results for the quarter ended June 30 - Earnings SummaryTwist Bioscience CorpTWST.OQreported a quarterly adjusted loss of 56 cents per share for the quarter ended June 30","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nL8N4401LO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IDNA","TWST","BK4588","GNOM","ARKG","BK4585","WDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656379387","title":"Tempus AI is Maintained at Hold by Stifel","url":"https://stock-news.laohu8.com/highlight/detail?id=2656379387","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656379387?lang=en_us&edition=fundamental","pubTime":"2026-08-03 20:17","pubTimestamp":1785759420,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TEM/analyst-ratings","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1861559042.SGD","TEM","BK4611","ARKG","BK4121","HEAL","TEMT","LU1861558580.USD","BK4613"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656375585","title":"Twist Bioscience Q3 EPS $(0.56) Misses $(0.50) Estimate, Sales $118.376M Beat $114.490M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2656375585","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656375585?lang=en_us&edition=fundamental","pubTime":"2026-08-03 19:20","pubTimestamp":1785756038,"startTime":"0","endTime":"0","summary":"Twist Bioscience Q3 EPS $(0.56) Misses $(0.50) Estimate, Sales $118.376M Beat $114.490M Estimate","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/quote/TWST","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","GNOM","IDNA","TWST","WDNA","BK4588","ARKG","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656847375","title":"Twist Bioscience FY26 Q3 Adjusted Ebitda Loss Narrows to $(11.3) Million; Revenue Rises 23% YoY to $118.4 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2656847375","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656847375?lang=en_us&edition=fundamental","pubTime":"2026-08-03 19:19","pubTimestamp":1785755969,"startTime":"0","endTime":"0","summary":"Twist Bioscience FY26 Q3 adjusted EBITDA loss narrows to $(11.3) million; revenue rises 23% YoY to $118.4 millionTwist Bioscience posted fiscal 3Q revenue of $118.4 million, up 23% year over year, bea","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nNDL89fGVm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4139","GNOM","WDNA","IDNA","TWST","ARKG","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656375882","title":"Twist Bioscience Q3 EPS USD -0.56","url":"https://stock-news.laohu8.com/highlight/detail?id=2656375882","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656375882?lang=en_us&edition=fundamental","pubTime":"2026-08-03 19:17","pubTimestamp":1785755843,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nPLXCMMPGG:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ARKG","IDNA","WDNA","BK4588","BK4585","BK4139","GNOM","TWST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656375862","title":"Twist Bioscience Outlook Q4 to Achieve Adjusted Ebitda Breakeven","url":"https://stock-news.laohu8.com/highlight/detail?id=2656375862","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656375862?lang=en_us&edition=fundamental","pubTime":"2026-08-03 19:17","pubTimestamp":1785755843,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nPLXCMMPGG:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ARKG","TWST","GNOM","IDNA","WDNA","BK4585","BK4139","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656375841","title":"Twist Bioscience Outlook FY Gross Margin to be Above 52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2656375841","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656375841?lang=en_us&edition=fundamental","pubTime":"2026-08-03 19:17","pubTimestamp":1785755843,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nPLXCMMPGG:6","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IDNA","GNOM","TWST","WDNA","BK4585","BK4139","ARKG","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656373040","title":"Twist Bioscience Posts Fiscal Q3 2026 Earnings Report and Investor Presentation Online","url":"https://stock-news.laohu8.com/highlight/detail?id=2656373040","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656373040?lang=en_us&edition=fundamental","pubTime":"2026-08-03 19:15","pubTimestamp":1785755750,"startTime":"0","endTime":"0","summary":"Twist Bioscience posts fiscal Q3 2026 earnings report and investor presentation onlineTwist Bioscience posted its fiscal Q3 2026 earnings report for the quarter ended June 30, 2026, alongside an inves","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nNDLD1H4F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WDNA","TWST","BK4139","BK4588","BK4585","ARKG","IDNA","GNOM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656887375","title":"Twist Bioscience Corp: for the Fourth Quarter, Twist Expects Total Revenue of Approximately $123 Million to $124 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2656887375","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656887375?lang=en_us&edition=fundamental","pubTime":"2026-08-03 19:15","pubTimestamp":1785755700,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nTUA8DSMMD:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TWST","IDNA","ARKG","BK4588","BK4585","GNOM","BK4139","WDNA"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":9,"totalSize":200,"code":"91000000","status":"200"}]}}